UMIN-CTR Clinical Trial

Recruitment status Preinitiation
Unique ID issued by UMIN UMIN000031303
Receipt No. R000035730
Official scientific title of the study Development of novel cytologic sampling device for cervical cancer screening
Date of disclosure of the study information 2018/02/14
Last modified on 2018/02/14 (Ver. 1)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Development of novel cytologic sampling device for cervical cancer screening
Title of the study (Brief title) Development of novel cytologic sampling device for cervical cancer screening
Region
Japan

Condition
Condition Cervical cancer and cervical precursor lesion
Classification by specialty
Obsterics and gynecology
Classification by malignancy Malignancy
Genomic information NO

Objectives
Narrative objectives1 Currently, a number of sampling devices for cervical cancer screening are on the market. However, there is no optimal sampling device that can handle any situation so that various devices are used for each purpose and facility. We have developed a new brush for sampling device now. This examination aims to develop more suitable sampling device using the new brush.
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1 Exploratory
Trial characteristics_2 Pragmatic
Developmental phase Phase I,II

Assessment
Primary outcomes Adverse event at cell collection and measurement the amount of collected cells
Key secondary outcomes Evaluate appropriateness of specimens and symptoms such as bleeding and pain

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Randomized
Randomization unit Individual
Blinding Single blind -participants are blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 4
Purpose of intervention Diagnosis
Type of intervention
Device,equipment
Interventions/Control_1 Existing device(Cervex)/Existing device(Cervex)
Interventions/Control_2 New device/Existing device(Cervex)
Interventions/Control_3 New device/Existing device(cotton swab)
Interventions/Control_4 New device/Existing device(YUINO BRUSH)
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Female
Key inclusion criteria Patients aged 20 years or older, patients scheduled to undergo cervical cytology diagnosis, patients who obtained their consent by written document
Key exclusion criteria Patients who doctor judged inappropriate for participation in this study
Target sample size 140

Research contact person
Name of lead principal investigator Toshiaki Shibata
Organization Hamamatsu University School of Medicine
Division name Obstetrics and gynecology
Address 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan 431-3192
TEL 053-435-2309
Email tshibata@hama-med.ac.jp

Public contact
Name of contact person Toshiaki Shibata
Organization Hamamatsu University School of Medicine
Division name Obstetrics and gynecology
Address 1-20-1 Handayama, Higashi-ku, Hamamatsu city, Shizuoka, Japan 431-3192
TEL 053-435-2309
Homepage URL
Email tshibata@hama-med.ac.jp

Sponsor
Institute Hamamatsu University School of Medicine
Institute
Department

Funding Source
Organization TEIBOW COMPANY
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization JAPAN

Other related organizations
Co-sponsor Neuroceuticals
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 浜松医科大学附属病院

Other administrative information
Date of disclosure of the study information
2018 Year 02 Month 14 Day

Progress
Recruitment status Preinitiation
Date of protocol fixation
2017 Year 07 Month 13 Day
Anticipated trial start date
2018 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2018 Year 02 Month 14 Day
Last modified on
2018 Year 02 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035730